| abstract |
The present invention relates to a compound of formula (I) below, or a pharmaceutically acceptable salt, solvate, ester or isomer thereof, useful for the treatment of a disease or condition mediated by LpxC. In another aspect, the present invention provides a method of treating a microbial infection. In yet a further aspect, the present invention provides a composition comprising one or more compounds of formula (I), an additional therapeutic agent for treating an LpxC receptor-mediated disease, and a pharmaceutical carrier. |